Voice Disorders: Clinical Trials

8 trials for Voice Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 not yet recruiting. 8 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 18Completed 7, Not yet recruiting 1
Phase 25Completed 5

Follow Voice Disorders: new trials by email Literature Review of Voice Disorders trials Research Report on Voice Disorders

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Extended-release Sodium Oxybate (Lumryz) in Spasmodic Dysphonia and Voice Tremor
sodium oxybate - Spasmodic Dysphonia, Laryngeal Dystonia
Phase 1Not yet recruitingKristina Simonyan82026-10-012026-04-28
Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia
Vibro-tactile stimulation - Spasmodic Dysphonia, Laryngeal Dystonia
Phase 1 / Phase 2CompletedUniversity of Minnesota402023-11-212026-07-15
DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia
DaxibotulinumtoxinA - Adductor Spasmodic Dysphonia, Voice Disorders
Phase 1 / Phase 2CompletedUniversity of California, San Francisco222023-10-132026-05-18
Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia
Zinc gluconate supplement, Botulinum toxin type A - Spasmodic Dysphonia
Phase 1 / Phase 2CompletedUniversity of Florida322023-08-012026-07-27
A Study of Local Administration of Autologous Mesenchymal Stromal Cells in Dysphonic Patients With Vocal Fold Scarring
MSC-KI-PL-204 - Hoarseness, Dysphonia
Phase 1 / Phase 2CompletedKarolinska University Hospital92021-03-012026-01-27
Effects of Octanoic Acid for Treatment of Essential Voice Tremor
Octanoic acid, Inactive capsule - Essential Voice Tremor, Vocal Tremor
Phase 1 / Phase 2CompletedSyracuse University172013-07-012018-08-20
Dextromethorphan to Treat Patients With Voice Spasms
Dextromethorphan, Lorazepam - Voice Disorders
Phase 1CompletedNational Institute of Neurological Disorders and Stroke (NINDS)652003-03-042017-07-02
Study of Air Stream in Voice Production
airway interruption test - Spastic Dysphonia, Healthy
Phase 1CompletedNational Institute of Neurological Disorders and Stroke (NINDS)302001-05-012008-03-04

Narrower conditions

Dysphonia (8)  ·  Aphonia (1)  ·  Dystonia (1)  ·  Essential Tremor (1)  ·  Hoarseness (1)  ·  Tremor (1)

Broader conditions

Laryngeal Diseases (8)  ·  Nervous System Diseases (8)  ·  Neurologic Manifestations (8)  ·  Otorhinolaryngologic Diseases (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Respiratory Tract Diseases (8)  ·  Signs and Symptoms (8)  ·  Dyskinesias (2)  ·  Central Nervous System Diseases (1)  ·  Movement Disorders (1)  ·  Respiration Disorders (1)  ·  Signs and Symptoms, Respiratory (1)

Interventions

Botulinum Toxins, Type A (2)  ·  Dextromethorphan (1)  ·  Lorazepam (1)  ·  Sodium Oxybate (1)  ·  gluconic acid (1)  ·  octanoic acid (1)

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS) (2)  ·  Karolinska University Hospital (1)  ·  Kristina Simonyan (1)  ·  Syracuse University (1)  ·  University of California, San Francisco (1)  ·  University of Florida (1)  ·  University of Minnesota (1)

Countries

United States (7)  ·  Sweden (1)

Top investigators

Clark Rosen, MD (1)  ·  Juergen Konczak, PhD (1)  ·  Neil Chheda (1)  ·  Patric Scicluna, Clin Research Manager (1)  ·  Soren Y Lowell, PhD (1)

Results publications

PMID 14718713, PMID 15210907, PMID 21594724, PMID 22454323, PMID 23408867, PMID 40850907, PMID 42002761

NIH funding

2019 (1), R03DC012429 (1)